This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Sanofi. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: David Rigal: Innovator in Pharmaceutical Chemistry
Introduction
David Rigal is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds that have potential therapeutic applications.
Latest Patents
David Rigal holds a patent for "Crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use." This invention relates to crystalline hydrates of a specific formula, where the variable n ranges from 2.1 to 2.5. The compound is particularly suitable for use as an antidiabetic medication. He has 1 patent to his name, showcasing his expertise in this specialized area.
Career Highlights
Rigal is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi involves research and development of pharmaceutical products that aim to improve patient outcomes. His innovative approach and dedication to his field have positioned him as a valuable asset to the company.
Collaborations
David Rigal collaborates with esteemed colleagues, including Martin Bröeckelmann and Norbert Nagel. These partnerships enhance the research and development process, allowing for a more comprehensive exploration of new pharmaceutical compounds.
Conclusion
David Rigal's contributions to pharmaceutical chemistry, particularly through his patented innovations, highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile